Registration for this event will close at 24 January 2024 at 23:45pm (GMT)
The Royal Society of Medicine is hosting its inaugural event dedicated to endometrial cancer, highlighting recent advancements in molecular understanding and multi-disciplinary treatment. Landmark clinical trials in the past year have reshaped clinical practices, incorporating molecular testing and immunotherapy in treatment decisions.
The meeting will cover updates on staging, pathology, molecular testing, surgery, radiotherapy, and drug treatments. Attendees will gain insights into rising incidence, survival rates, disparities, and prevention strategies for endometrial cancer.
The event also focuses on making multidisciplinary decisions, understanding immunotherapy trials, managing treatment-related toxicities, and staying informed about the latest advances and future perspectives in endometrial cancer treatment.